Strong evidence for T cell activation in atopic dermatitis disease pathogenesis exists, as demonstrated by the clinical efficacy of therapeutic T cell cytokine blockade. The subsets of human T cells capable of contributing to pathology of this disease remain poorly defined, lending importance to the characterization of T cells and their cytokines within active skin […]
Read More